Robert Riddle, Ph.D.

Job Title
Program Director
Photo of Robert Riddle
Division of Neuroscience
Cluster, Section, or Program
Areas of Interest

Portfolio: Early pattern formation; cortical, cerebellar, midbrain, and hindbrain development; chromatin structure and function in the nervous system; epigenetic mechanisms; development and use of animal model systems; Joubert and Dandy-Walker Syndrome; Chiari Malformations; Down Syndrome and diseases related to intellectual developmental disorders; Fragile X Tremor Ataxia (FXTAS)    

Additional Keywords: Developmental neuroscience, early CNS pattern formation; cell fate determination; stem cells related to cerebellum; neural epigenetics, higher order chromatin structures, miRNA; animal models and animal model resources; Intellectual Disability; Intellectual and Developmental Disorders (IDD); cognition-related disorders, Klinefelter’s Syndrome, Turner’s Syndrome; developmental disorders of the cortex, dysplasia, microcephaly, lissencephaly; Pitt Hopkins; hypothalamic and pituitary development; music and health; birth defects related to neural development disorders

Contact Email
Contact Number

Dr. Robert Riddle is a program director in the Neurogenetics Cluster. Prior to joining NINDS in early 2005, Dr. Riddle was a program director at the National Institute on Drug Abuse. His programmatic interests are neural development and molecular genetics. Specifically, his portfolio in developmental biology contains a number of studies focused on axonal guidance, pattern formation, and cerebellar development. Utilizing both vertebrate and invertebrate animal models is also an interest. Furthermore, Dr. Riddle participates in a number of NIH groups focusing on advancing and distributing mouse mutants. He is a member of a set of trans-NIH committees focused on: genomic resources, mouse knock outs, zebrafish, and RNAi. Prior to coming to the NIH in 2002, Dr. Riddle was a faculty member in the Department of Cell and Developmental Biology at the University of Pennsylvania School of Medicine. He was a postdoctoral fellow in Dr. Cliff Tabin’s lab at Harvard Medical School. He received his PhD in Molecular Biology from Northwestern University.